» Authors » Robert Jan Lebbink

Robert Jan Lebbink

Explore the profile of Robert Jan Lebbink including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 2229
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma N, Zhang M, Zhou J, Jiang C, Ghonaim A, Sun Y, et al.
Emerg Microbes Infect . 2024 Sep; 13(1):2400559. PMID: 39222358
Porcine deltacoronavirus (PDCoV) is an emerging pathogen that can cause severe diarrhoea and high mortality in suckling piglets. Moreover, evidence of PDCoV infection in humans has raised concerns regarding potential...
2.
Zheng S, Verjans G, Evers A, van den Wittenboer E, Tjhie J, Snoeck R, et al.
Antiviral Res . 2024 Jun; 228:105950. PMID: 38944159
Herpes simplex virus type 1 (HSV-1) is a neurotropic alphaherpesvirus that establishes a lifelong infection in sensory neurons of infected individuals, accompanied with intermittent reactivation of latent virus causing (a)symptomatic...
3.
Zheng S, Rumke L, Rubio B, Rogers M, van Sluis G, Kuball J, et al.
Open Forum Infect Dis . 2024 May; 11(5):ofae250. PMID: 38798899
We present an immunocompromised patient with a multiresistant herpes simplex virus-1 reactivation with a rare mutation (A605V) in the viral DNA polymerase gene. Next-generation sequencing suggests the presence of multiple...
4.
Cremer T, Hoelen H, van de Weijer M, Janssen G, Costa A, Van Veelen P, et al.
PLoS One . 2024 May; 19(5):e0287877. PMID: 38787820
Type 1 diabetes (T1D) is characterized by HLA class I-mediated presentation of autoantigens on the surface of pancreatic β-cells. Recognition of these autoantigens by CD8+ T cells results in the...
5.
Longo Y, Moreno Mascaraque S, Andreacchio G, Werner J, Katahira I, De Marchi E, et al.
Front Immunol . 2024 May; 15:1360140. PMID: 38711513
Introduction: Modified Vaccinia Virus Ankara (MVA) is a safe vaccine vector inducing long- lasting and potent immune responses. MVA-mediated CD8T cell responses are optimally induced, if both, direct- and cross-presentation...
6.
Langedijk A, Vrancken B, Lebbink R, Wilkins D, Kelly E, Baraldi E, et al.
Nat Commun . 2024 Apr; 15(1):3083. PMID: 38600104
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infection in young children and the second leading cause of infant death worldwide. While global circulation has...
7.
Singh A, Mommers-Elshof E, Vijver S, Jansen J, Gonder S, Lebbink R, et al.
Cancer Immunol Immunother . 2024 Jan; 73(1):16. PMID: 38236251
Collagen expression and structure in the tumour microenvironment are associated with tumour development and therapy response. Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is a widely expressed inhibitory collagen receptor. LAIR-2 is a...
8.
Langedijk A, Vrancken B, Lebbink R, Evers A, Pieciak R, Lemey P, et al.
Pediatr Infect Dis J . 2023 Jul; 42(11):e421-e423. PMID: 37523582
No abstract available.
9.
Wilkins D, Langedijk A, Lebbink R, Morehouse C, Abram M, Ahani B, et al.
Lancet Infect Dis . 2023 Mar; 23(7):856-866. PMID: 36940703
Background: Nirsevimab is an extended half-life monoclonal antibody to the respiratory syncytial virus (RSV) fusion protein that has been developed to protect infants for an entire RSV season. Previous studies...
10.
Le-Trilling V, Banchenko S, Paydar D, Leipe P, Binting L, Lauer S, et al.
EMBO J . 2023 Feb; 42(5):e112351. PMID: 36762436
Human cytomegalovirus (CMV) is a ubiquitously distributed pathogen whose rodent counterparts such as mouse and rat CMV serve as common infection models. Here, we conducted global proteome profiling of rat...